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Day 1:    
 
Invited Speakers Abstracts 
 
Novel, potent and selective inhibitors of Plasmodium N-myristoyltransferase: a new antimalarial 
mode of action 
Professor Edward Tate, Department of Chemistry, Imperial College London, UK 
Chemical validation of new antimalarial targets is urgently required in view of rising resistance to current 
drugs. The enzyme N-myristoyltransferase (NMT), catalyses attachment of myristate to protein substrates 
(N-myristoylation), and chemical biology approaches have been used to demonstrate that NMT is an 
essential and chemically tractable target in human malaria parasites, both in vitro and in vivo. NMT 
inhibition cause catastrophic and irreversible failure to assemble critical subcellular parasite organelles, 
resulting in potent and selective antiparasitic activity in both blood and liver stage. This novel mechanism 
circumvents clinical resistance, and represents a promising avenue to novel antimalarial drugs. 
 
How genomics is contributing to the fight against artemisinin-resistant malaria 
Dr Pedro Cravo, Instituto de Patologia Tropical e Saúde Pública/Universidade Federal de Goiás, Brazil 
Arttemisinin (ART) resistance has recently evolved in human malaria parasites. Widespread ART 
resistance would be catastrophic because there are no effective alternative treatments availble. This talk 
will focus on the recent contributions in the field of genomics for our understanding of the genetics of 
resistance to artemisinin in the human malaria parasite Plasmodium falciparum. Specific emphasis will be 
placed on how genomics has contributed to the recent discovery of a number of molecular markers that are 
being used in real time to track the appearance and spread of artemisinin resistance in natural parasite 
populations. 
 
Computational modelling of the interactions between antimalarial drugs and hemozoin crystal 
faces 
Dr Marcus C. Durrant, Northumbria University, London, UK 
Several antimalarial drugs are known to act by interfering with the parasite’s ability to detoxify iron(III) 
ferriprotoporphyrin (FePPIX) by crystallization to haemozoin. In this work, a combination of quantum 
calculations and molecular modelling has been used to investigate the binding of five quinine-like drugs 
and five chloroquine-like drugs to free FePPIX and to the crystal faces of haemozoin.  The results suggest 
that all 10 drugs have a common mode of action, involving formation of a strong Fe-O bond.  We have used 
this model to initiate a computational search for novel antimalarial drugs. 
 
Towards next generation of medicines to meet the ambitious goal of malaria eradication 
Dr Benjamin Blasco, Medicines for Malaria Venture, Switzerland 
For new medicines to meet with the ambitious goal of malaria eradication, they must be able to block 
transmission, prevent relapse of dormant forms and contain or circumvent drug resistance. In the absence 
of a highly effective vaccine, prophylactic treatments are also needed to protect patient populations. During 
this presentation, the strategy of Medicines For Malaria Venture (MMV) - a not-for-profit public-private 
partnership – to tackle these challenges will be presented through the description of current mainstay 
treatments along with a selection of emerging new clinical molecules from our portfolio. 
 
Role of hemozoin in the pathogenesis of malaria-associated acute respiratory distress syndrome 
Professor Philippe Van den Steen, Laboratory of Immunobiology, Rega Institute for Medical Reseach, 
University of Leuven – KU Leuven, Belgium 
Malaria-associated acute respiratory distress syndrome (MA-ARDS) is an often lethal complication which 
occurs mainly in adult patients. To investigate the pathogenesis and therapeutic options, we developed a 
mouse model of MA-ARDS with Plasmodium berghei NK65. Similar to postmortem findings in patients, MA-
ARDS in our model is characterized by extensive interstitial and alveolar edema, hyaline membrane 
formation, microhemorrhages, and the presence of abundant inflammatory infiltrates in lungs. These 
infiltrates mainly consist of monocytes and macrophages, lymphocytes and some neutrophils. Interestingly, 
we observed abundant accumulation of hemozoin or malaria pigment in the lungs. Further investigations 
indicated that hemozoin induces pulmonary inflammation and is an important pathogenic factor in MA-
ARDS. 
  
 
 
Polyamidoamine nanoparticles: A versatile dual tool for malaria therapeutics and prophylaxis 
Dr Xavier Fernàndez Busquets, Research Associate, Institute for Bioengineering of Catalonia, Barcelona, 
Spain 
We have developed poly(amidoamine)-derived nanovectors that combine into a single chemical structure 
drug encapsulating capacity, antimalarial activity, low unspecific toxicity, specific pRBC targeting, optimal 
in vivo activity, and affordable synthesis cost. Our recent data suggest that the antiparasitic mechanism of 
PAAs can be based on blocking the erythrocyte invasion of egressed parasites. The ensuing prolonged 
exposure of the pathogens to the immunitary system might be applied to the design of new malaria 
vaccination approaches where PAAs could play a dual role as carriers of antimalarial drugs and as 
vaccination adjuvants. This unexpected synergistic effect combining therapeutics and prophylaxis 
represents a radically new approach to the treatment of malaria for which we propose the new term 
theralaxis. 
 
Regulators of Plamsodium falciparum Protein Phosphatases: new means to control malaria 
Dr Jamal Khalife, Univ Lille Nord de France, Cente National de la Recherche Scientifique, Lille Cedex, France 
Protein phosphatases are enzymes involved in many cellular essential functions. The most important and 
studied phosphatases are the Protein Phosphatase type 1 (PP1) and type 2A (PP2A). The selective action of 
these phosphatases, are controlled by their capacity to bind several protein regulators. In P. falciparum, 
PP1 and PP2A are known to be crucial for parasite (sur)vival. We undertook the characterization of 
interactors/regulators of both phosphatases. This allowed to characterize three regulators of PfPP1 
(PfLRR1, PfI2, PfI3) and one regulator of PP2A (PfPTPA), which have been shown to participate in the 
regulation of the cell cycle. Genetic approaches showed that these regulators of PP1, which present several 
important differences with their human homologs, are as essential as PP1 itself for P. falciparum survival. 
We explored the binding motifs of these regulators to PP1 and showed that peptides derived from these 
motifs, exhibited anti-plasmodial activity against blood stage parasites in vitro. 
 
 
 
Oral Presentation Abstracts 
Oral presentations will be added after the submission deadline  
 
OVERCOMING DRUG RESISTANCE IN MALARIA BY INHIBITING EFFLUX 
Professor David Peyton, Department of Chemistry, Portland State University, Portland, Oregon, U.S.A. 
We are developing a class of hybrid molecules made from a chloroquine-like (CQ-like) moiety and a 
chemosensitizer (reversal agent; RA) against chloroquine resistance (CQR) in malaria. We have shown 
these molecules to have low-nanomolar in vitro IC50 values against all strains of malaria tested so far, 
whether CQ-sensitive or CQ-resistant, often surpassing the activity of even CQ against chloroquine-
sensitive strains of P. falciparum. Here we report on the progress of a lead compound, PL69/DM1157, and 
its progress along its preclinical development pathway. This report will cover results from in vitro 
evaluations (including off-target activity), rodent toxicology, and pharmacokinetics, as well as initial initial 
second-species work. Aspects of the scale-up chemistry for GMP-production will be discussed, as well as 
the potential for suppressing the evolution of resistance against such a new drug. The advantages of a drug 
with the projected safety and efficacy profiles as favorable as chloroquine’s, but without the associated 
resistance would be considerable. 
 
NEW ANTIMALARIAL COMPOUNDS FROM A PLANT USED TRADITIONALLY IN BENIN 
J. Bero, M.-F. Herent, G. Schmeda-Hirschmann, M. Frédérich, J. Quetin-Leclercq 
Université catholique de Louvain, Louvain Drug Research Institute, Pharmacognosy Research Group, 72 
Avenue E. Mounier, B1.72.03, B-1200 Brussels, Belgium 
 
Parasitic diseases are still responsible for many health problems. Among them, African trypanosomiasis or 
sleeping sickness caused by Trypanosoma brucei, malaria transmitted by Plasmodium species of which the 
most dangerous is Plasmodium falciparum and leishmaniasis. Plant biodiversity and knowledge of 
traditional healing allow, as it was the case for artemisinin, to open new ways in the field of therapeutic. In 
the work we will present, we analyzed the activity of several plants from Benin selected by 
ethnopharmacological and bibliographical studies. These plants are used in traditional medicine as 
antimalarials. Crude extracts from powders of leaves, twigs, roots or aerial parts were prepared by 
maceration. These extracts were studied for their antiparasitic activities by in vitro tests on Plasmodium 
falciparum, Trypanosoma brucei brucei and Leishmania mexicana mexicana. In addition, cytotoxicities were 
analysed to determine the selectivity of crude extracts. The extracts of Keetia leucantha were selected for 
further investigations. So we tested the in vivo antimalarial activity of the dichloromethane extract of twigs 
which showed 40.7 % inhibition in mice infected by Plasmodium berghei at 100 mg/kg/day and the total 
aqueous extract which had a 30.8% inhibition at 200 mg / kg / day. 
Known antiparasitic compounds were identified and quantified by LC-MS in the dichloromethane extract. 
As they could not account for the total activity observed, we isolated by bioguided fractionation several 
triterpenic esters, vanillin derivatives, a sterol and a coumarin. The structure determination of isolated 
compounds was performed by NMR studies and high resolution mass spectrometry. The isolated 
compounds were then studied in vitro and in vivo for their antiplasmodial activities. Several of them 
showed a sub-micromolar antiplasmodial activity, including some triterpenic esters which are about 10 
times more active than ursolic acid.  
 
References 
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RECYCLING CLASSICAL DRUGS: TOWARD LOW-COST ANTIMALARIALS  
Ana Gomes1,2, Bianca Pérez1, Cátia Teixeira2, José R. B. Gomes2, Paula Gomes1* 
1UCIBIO/REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, 
Rua do Campo Alegre 687, P-4169-007 Porto, Portugal 
2CICECO, Universidade de Aveiro, Campus Universitário de Santiago 3810-193 Aveiro, Portugal 
*pgomes@fc.up.pt 
 
Developing new drug products is a costly and time-consuming process, which is a delicate issue when 
addressing diseases of poverty; a low-cost reduced-risk strategy towards sustainable drug development 
may pass by performing simple chemical modifications on classical drugs (recycling), or by identifying new 
therapeutic uses for shelved drugs (rescuing), or for drugs approved to treat a specific disease while being 
potentially relevant against other therapeutic targets (repurposing) [1]. For the past few years, our group 
has been working on the recycling of classical antimalarials chloroquine (1) and mepacrine (2), whose 
originally thrilling antimalarial properties gave place to disappointing news about, respectively, emergence 
of parasite resistance and toxicity issues; starting from the heteroaromatic cores of these two antimalarial 
classics, we performed simple chemical reactions to obtain new derivatives, whose promising antimalarial 
properties will be presented [2-4].   
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EPIDEMIOLOGICAL AND PROPHYLACTIC DATA OF IMPORTED MALARIA IN THE MILITARY HOSPITAL OF 
INSTRUCTION MOHAMMED THE FIFTH OF RABAT, MOROCCO. 
El-Houcine Sebbar, Hafida Naoui, K. Sbai Idrissi, Badre Eddine Lmimouni 
Service of Medical Parasitology & Mycology, the Military Hospital of Instruction Mohammed the fifth, PO 
Box number 1018, Rabat, Morocco. 
 
Introduction: For his many interventions in sub-saharian Africa, the Moroccan army has gained 
considerable experience in management of imported malaria. Chemoprophylaxis is stratified according to 
drug sensitivity of Plasmodium in the host country. The use of impregnated mosquito nets is a key strategy 
in the army. The aim of our study is to investigate the epidemiology of imported malaria and the 
prophylactic and therapeutic approach. 
 
Materials and methods: This is a prospective study which took place from 1st January 2005 to December 
31 2009 at the Military Hospital of Instruction Mohammed the fifth in Rabat. All military personnel with a 
search request of Plasmodium in the blood are included. Data are collected in real time on a standardized 
form. 
 
Results: During the study period, 658 applications corresponding to 612 patients are included and 57 
patients (9,31%) were diagnosed positive for Plasmodium spp. All patients were male and the average age 
is 33,6 years. The average stay is 182 days. Plasmodium falciparum is responsible for most processes, only 
in 56,14% of cases (N = 32), and in combination with other Plasmodium species in 14,03% of cases (N = 8). 
87,7% (N = 50) had taken chemoprophylaxis. As for physical protection, it was applied in only 59,64% of 
cases (34 cases). 
 
Conclusion: This study allowed us to describe the epidemiological characteristics of imported malaria in 
the Military Hospital of Instruction Mohammed the fifth of Rabat, and identify a number of problems on 
disease prevention. 
 
Keywords: Imported malaria, Army, Plasmodium falciparum, Epidemiology, Chemoprophylaxis. 
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EXPLORING NEW HYDRAZINE AND HYDRAZIDE QUINOXALINE 1,4-DI-N-OXIDE DERIVATIVES AS 
POTENTIAL ANTIMALARIALS 
M. Quiliano[1,2], A. Pabón[3], C. Barea[1], S. Galiano[1,2], I. Aldana[1,2*] 
[1]Department of Organic and Pharmaceutical Chemistry, Facultad de Farmacia. Universidad de Navarra, 
c/Irunlarrea 1, 31008 Pamplona, Spain. Email*: ialdana@unav.es  
[2]Institute of Tropical Health (ISTUN), Universidad de Navarra, c/Irunlarrea 1, 31008 Pamplona, Spain. 
[3]Malaria Group, Universidad de Antioquia, Medellín, Colombia. 
 
Malaria is one of the world’s most important tropical parasitic diseases. Mortality due to malaria is 
estimated to be over 1 million deaths annually and this situation is worsened by the spread of drug-
resistant strains of the parasite. In the present study, a series of 19 quinoxaline 1,4-di-N-oxide derivatives 
were designed, synthesized and evaluated in vitro against infectious pathogens Plasmodium falciparum 
(3D7 strain chloroquine-sensitive and FCR-3 strain chloroquine-resistant) and Leishmania infantum. 
Among them, 14 novel compounds correspond to hydrazine and hydrazide derivatives. Their cytotoxicity 
and selectivity were also evaluated against HEGP-2 cells. The in silico ADMET properties were calculated 
for all compounds. One hydrazine derivative was found to inhibit 50% of Plasmodium growth at 0.24 µM. 
Hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives constitute a new class of antimalarial 
compounds. It can potentially serve as templates for future drug-optimization and drug-development 
efforts for use as therapeutic agents in developing countries. 
 
NEW QUINOXALINE DERIVATIVES OF CHALCONE AS ANTI-PLASMODIUM FALCIPARUM AGENTS: 
SYNTHESIS, BIOLOGY EVALUATION AND STRUCTURE-ACTIVITY RELATIONSHIP 
S. Galiano [1,2], A. Gil [1], A. Pabón [3], A. Burguete [1,4], S. Pérez-Silanes [1,2], E. Deharo [5], A. Monge [2] 
and I. Aldana [1,2] 
 
[1] Department of Organic and Pharmaceutical Chemistry. University of Navarra, Irunlarrea, s/n, 31008-
Pamplona, Spain. [2] Institute of Tropical Health, University of Navarra, Pamplona, Spain. [3] Group of 
Malaria. Universidad de Antioquía, Medellín, Colombia. [4] Instituto de Química Avanzada de Cataluña, 
Consejo Superior de Investigaciones Científicas, Barcelona, Spain; [5] PHARMA-DEV, UMR 152 IRD-UPS, 
Université Paul Sabatier, Toulouse, France. e-mail sgaliano@unav.es 
 
Malaria is one the most important devastating parasitic disease with an estimated 219 million cases and 
660,000 deaths in 2010 in 104 endemic countries1. Five species of Plasmodium parasites are the 
responsibles of malaria, but Plasmodium falciparum is the most dangerous form of the malaria parasite 
and it is responsible for a very high percentage of clinical attacks and Plasmodium vivax is the most 
widespread2.  
 
The appearance and spreading resistance of Plasmodium falciparum to the existing anti-malarial drugs is 
one of the biggest obstacles in the fight against malaria. Novel antimalarial drugs, structurally diverse, with 
rapid efficacy, minimal toxicity and low cost are urgently needed to avoid cross-resistances.  
 
Based on the demonstrated antiplasmodial activity of the quinoxaline derivatives3 and the chalcone 
compounds4 and with the aim of establishing the structural requirements in order to optimize the activity, 
new series of quinoxaline and quinoxaline 1,4-di-N-oxide  analogs of chalcone and other compounds 
derived from them have been developed and evaluated against the FCR-3 cloroquine-resistant Plasmodium 
falciparum strain (Fig. 1)5. The SAR study demonstrated the importance of an enone moiety linked to the 
quinoxaline ring for obtaining better antimalarial activity. Compounds 1a and 2a showed the best 
antiplasmodial activity. 
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SYNTHESIS AND BIOLOGICAL EVALUATION OF NEW AMINOQUINOLINETHANOLS AS ANTIMALARIAL 
DRUGS VIA AN ENANTIOSELECTIVE AMINOHYDROXYLATION PATHWAY 
G. Bentzinger*, A. Dassonville-Klimpt, C. Demailly-Mullié, P. Sonnet  
Laboratoire LG2A, CNRS FRE 3517, UFR de pharmacie, 1 rue des Louvels, Université Picardie Jules Verne,  
80037 Amiens cedex 1 FRANCE 
*:guillaume.bentzinger@u-picardie.fr  
 
Malaria, due to protozoa belonging to the genus Plasmodium, is the 5th most lethal infection in the 
world.[1] The emergence and spread of multiple drug resistances among strains of these parasites pose a 
serious public health problem. New antimalarial drugs are therefore needed and this is why our team is 
involved in the design and synthesis of new antimalarial compounds. Mefloquine and its derivatives remain 
very attractive targets for the synthesis of more potent and less toxic analogues. Recently, we have 
described the asymmetric synthesis and biological activity of aminoquinolinemethanols.[2] In this series, 
the most active molecule is the aminoquinolinemethanol with a S configuration and a pentyl group (IC50 = 
6.98 nM on the chloroquine-resistant W2,  strain). To further understand the structure-activity 
relationships in these molecules, we next endeavored to study the influence of the position of the amino 
group and the alcohol group on the antimalarial activity. We present here the synthesis and biological 
evaluation of new aminoquinolinethanols, analogues to the most active aminoquinolinemethanols 
described previously.[2] 
 
References: 
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In-depth immunoprofiling as tool to establish immune correlates of protection 
Dr. Elke Bergmann-Leitner, Chief, Flow Cytometry Center, MVDB/USMMRP/WRAIR, Silver Spring, MD, USA 
Immune correlates of protection against Plasmodia have been elusive, slowing the rational design of an 
effective vaccine. Repeated exposure to Plasmodium does not yield protection against subsequent 
infection, but a form of immune-tolerance. Therefore, “natural immunity” to malaria does not provide a 
model to study protection. Immune correlates of protection against malaria are likely complex and 
identifying correlates or surrogate markers of protection requires immunoprofiling with unprecedented 
depth. Samples from trials of malaria vaccines with measureable sterile protection were analyzed and 
provide a first glimpse of the landscape of antigen-specificity and types of immune responses associated 
with protective, sterile immunity. 
 
 
 
 
 
 
 
 
Systematic analysis of malaria-related research investments awarded to UK institutions 1997-
2013: where’s the money gone? 
Dr Michael Head, Network Manager, Infectious Disease Research Network, Based at the UCL Farr Institute, 
London, United Kingdom 
Across this seventeen year time period, there has been approximately £490m of research investment into 
malaria research, across 621 separate studies (this compares with £609m for HIV, and £226 million for 
tuberculosis, for example). This talk would go into more detail about the breakdown of the direction of 
spend for malaria research in the UK, as well as quantifying the relative levels of investment against the 
burden of disease. It would also highlight gaps in the UK research portfolio and discuss potential priority 
areas for funders to consider. 
 
Development and evaluation of a direct on blood PCR-NALFIA system (DIAGMAL): bringing 
molecular diagnostics to the field 
Dr Henk Schallig, Royal Tropical Institute / Koninklijk Institut voor de Tropen (KIT) - Parasitology Unit, 
Amsterdam, The Netherlands 
Molecular tools allow for specific/sensitive malaria diagnosis, but current formats, like PCR with gel-
electrophoresis, are difficult to implement in resource poor settings. Therefore, a simple, fast, 
sensitive/specific molecular diagnostic platform, direct on blood PCR combined with nucleic acid lateral 
flow immunoassay  to detect amplified PCR products of Pan-Plasmodium and human GAPDH (internal 
control) was developed. This test format circumvents DNA extraction and complex read-out systems. The 
diagnostic  was favorably evaluated under laboratory conditions, multi-country ring trial and two malaria 
endemic countries, which brings molecular diagnostics for malaria closer to field use in disease endemic 
countries where resources are often limited. 
 
Beating Malaria: A ten-year retrospective report from Nigeria 
Mr. Emmanuel Amadi, Department of Medical Microbiology, College of Medicine, Enugu State University of 
Science and Technology, Nigeria 
E.C. Amadi, T.N  Nwagu, B.A.F,  Ngwu and M.N. Ugwuanyi. 
In endemic regions of malaria, the actual incidence and mortality rates are unknown due to incomplete 
reporting. Major factor against this is the irritating sampling technique (finger prick, etc) which are 
repulsing to the volunteers - that then becomes reluctant - necessitating need for a more accurate estimate 
through clinical malaria.  Medical records of patients in two different hospitals in Enugu (Eastern Nigeria) 
between January – December of 2005 to 2009 and 2010 to 2014 were critically studied. Ages, sexes, 
occupations, locations, and monthly plus yearly incidences of diagnosed cases of malaria were analyzed. 
27,100 records were examined in the first hospital and 24,180 in the second hospital. The result of the first 
hospital revealed a yearly statistically significant increase in diagnosed cases of malaria from 2005 to 2009 
(38%, 395, 42%, 43% and 42%, in yearly ascending order). Prevalence rates were highest during the drier 
periods of the 5 year.  > 35 years age-group has the highest incidence (56.25%) and lowest incidence in 1-
14 years (8.75%). Females (52.2%) were diagnosed more of malaria than the males (47.8%). Farmers and 
cattle herdsmen (30% and 25%, respectively) were most affected while students and office workers 
(11.25% and 12.5%, respectively) has the lowest incidence. The second hospital (2010 – 201`4) revealed a 
slight but very high percentage decline down the years (98.5%, 96.9%, 57%, 95.6% and 96.3%). 
Prevalence rate was also highest during the drier period of the year. Females (56.4%) again were more 
affected than the men (43.6%). Farmers (25%) were also most affected, but cattle herdsmen (7.5%) 
surprisingly were least affected here. In reverse, 01 – 14 age-group (45.1%) were most affected in this 
case;   >   35 years were next (27.8%) and 30 – 34 years were least affected (12%). In conclusion, besides 
evidences of still serious lag in malaria combat and control, some niches apparently serves as “reservoirs” 
of the disease in form of the mosquitoes vectors and Plasmodium sp etiologic agent that seeds other parts 
of the country/world of the disease and hinder the global efforts.. Plasmodium-parasitaemia-negative is 
advocated for cure, and not mere physical fitness. 
 
The role of visiting friends and relatives (VFRS) in imported malaria 
Assistant Professor Paola Di Carlo, Department of Sciences for Health Promotion and Mother-Child Care, 
University of Palermo, Italy 
With the integration of immigrants in their host countries, a new, special group of travellers - Visiting 
Friends and Relatives (VFRs) - has emerged over time. The term VFRs refers in particular to immigrants 
who move to high-income countries from countries where socio-economic status is low, and regularly 
return to their country of origin, sometimes for fairly long periods of time, to visit their friends and 
relatives or, where women are concerned, also to give birth and spend the post-partum period with their 
family.  Precisely because they are “special tourists”, VFRs are considered to be at higher risk than other 
regular travellers of contracting diseases like tuberculosis, HIV and malaria. In fact, because they still feel 
ethnically integrated in their country of origin, many of them do not take adequate preventive measures to 
reduce risks to their health.Although many studies have been conducted on this particular group of 
travellers, we still lack sufficient information, in our country especially, that enables us to undertake 
suitable prevention initiatives. Malaria is the most frequently contracted infection among VFRs, with a 
significant difference (p<0.001) compared to more recent immigrants and other categories of travellers. 
More than 75% of imported malaria cases occur in immigrants, and almost all of them are in the Visiting 
Friends and Relatives category. In more than 90% of cases the infection is caused by P. falciparum and 
regards individuals from sub-Saharan African countries. It is important to note that almost all the women 
and children with imported malaria belong to the VFRs category.    
 
 
Oral Presentation Abstracts 
 
SEX HORMONES DOWN REGULATE THE IMMUNE RESPONSE IN P. berghei ANKA INFECTED MICE. 
M Legorreta-Herrera, NA Mosqueda-Romo, KE Nava-Castro, AL Morales-Rodríguez, FO Buendía-González 
and J Morales-Montor.  
Laboratorio de Inmunología Molecular, Facultad de Estudios Superiores Zaragoza, Universidad Nacional 
Autónoma de México, Batalla 5 de mayo esq. Fuerte de Loreto, Iztapalapa 09230, México, D.F. México 
 
Pathology and mortality in malaria is different between females and males, this sexual dimorphism may 
have important implications for vaccines and drug’ effects. However, little is known about the mechanisms 
mediating these sex differences. Since the main differences between sexes are dictated by sex hormones 
and these molecules are mainly produced by gonades, in this work we studied the effect of gonadectomy on 
the immune response to P. berghei ANKA in CBA/Ca mice. We evaluated parasitaemia, splenic index, the 
cells involved in the immune response such as CD3+, CD4+, CD8+, NK+, B+ and macrophages in the spleens of 
female and male mice infected with P. berghei ANKA. In addition, we measured antibody and cytokine 
levels in blood. Gonadectomy increased T+ and B+ splenic cells in both sexes but increased Mac-3+ cells only 
in male mice. Interestingly, gonadectomy decreased the NK+ cell population only in male mice. Female mice 
developed higher antibody levels than males. Contrary to our expectations, gonadectomy increased the 
synthesis of IgG1, IgG2b, IgG3 and total IgG in female mice, indicating negative regulation of antibody 
production by female sex hormones. Gonadectomy increased the production of Tumour Necrosis Factor 
alpha (TNF-) and Interleukin-6 (IL-6) only in female mice, suggesting that female sex hormones have anti-
inflammatory properties. This work, demonstrates that sex hormones supress the immune response and 
should be considered when designing malaria vaccines. 
 
This work was supported by DGAPA, UNAM Grant IN216914 
 
SERUM SELENIUM CONCENTRATION IN PATIENTS WITH VIVAX AND FALCIPARUM MALARIA BY 
ATOMIC ABSORPTION SPECTROSCOPY 
Mohsin Ali Baloch1,  Saira Baloch2 
1Faculty of Pharmacy, University of Sindh, Jamshoro, Pakistan 
2 Medical Research Centre, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan 
 
Abstract 
Malaria is one of the most serious tropical diseases in the world and has been a health risk to humans for 
many generations. It is very widespread disease, covering many areas of Europe, North America, South 
America, Asia and Africa. It is also a major public health problem in Pakistan. Selenium is an essential 
antioxidant trace mineral for the human body. In the present study, Selenium concentration was 
determined in the serum of Patients with vivax and falciparum malaria (n=50) with comparison to healthy 
control subjects (n=50). Selenium was determined using Atomic Absorption Spectroscopy (AAS, Model 
Varian A-20). The serum concentration of selenium determined to be in vivax 42.92±1.21, in falciparum 
41.72±1.1 malaria were lower as compared to the 49.01±1.01in healthy control subjects. It is concluded 
that selenium supplementation should be recommended in the therapies used for the management in 
patients with viavx and falciparum malaria. 
 
Key words: Vivax, Falciparum, Selenium, Atomic Absorption Spectrometry 
amohsin1710@gmail.com  
 
 
 
 
 
 
 
 
 
 
ANTIPLASMODIAL POTENTIAL OF THLASPI ARVENSE (BRASSICAEAE) USED IN TRADITIONAL 
MEDICINE 
N.S. Walter1, U. Bagai1* 
1Parasitology Laboratory, Department of Zoology, Panjab University, Chandigarh, 160014, India. 
 
Abstract 
Traditionally used medicinal plants are rich sources of new drugs against malaria and other infectious 
diseases. Thlaspi arvense (field pennycress) is used in traditional herbal medicine as febrifuge, blood tonic 
and blood purifier. The present study has been designed to explore its in vitro and in vivo antimalarial 
efficacy. Phytochemical screening of extract revealed the presence of diterpenes, triterpenes, steroids, 
anthraquinones and phytosterols. Ethanolic whole plant extract of Thlaspi arvense (EWETA) was found to 
inhibit schizont maturation of both chloroquine-sensitive (MRC-2) and resistant (RKL-9) strains of 
Plasmodium falciparum with IC50 <5µg/ml and =5µg/ml respectively. The extract revealed no signs of 
toxicity against both HeLa cells and normal fibroblasts with CC50>1000µg/ml.  Selectivity index of EWETA 
was calculated to be >200 and =200 for MRC-2 and RKL-9 strains of the parasite respectively with both cell 
lines. The extract also exhibited considerable repository and curative against Plasmodium berghei (NK-65) 
in vivo. In case of repository activity, maximum chemo-suppression of 91.75% was observed on day 7 at a 
concentration of 500mg/kg in comparison to positive control (78.78%). However, maximum curative 
efficacy in established infection (91.93%) was observed at an intermediate dose of 100mg/kg. Mean 
survival time of 27.33±1.63 days was also observed at this concentration, which was extremely statistically 
significant (p<0.0005) in comparison to infected control which died by day 9 post inoculation. Based on 
WHO recommendations EWETA can be classified as highly active antimalarial against chloroquine-
sensitive (MRC-2) strain and possesses promising antimalarial efficacy against chloroquine-resistant (RKL-
9) strain. High selectivity index (SI>10) also establishes field pennycress as an active antimalarial. 
Considerable preventive potential at a dose of 500mg/kg indicates that higher doses of the extract are 
more effective in preventing parasite development in the host. However, intermediate dose is more 
effective in curing established infection as well as non-toxic to host leading to enhancement of mean 
survival time of mice. Hence, present study provides scientific evidence for the traditional usage of this 
plant as an antipyretic agent in the Himalayan region. Further studies are being carried out to isolate the 
active components responsible for its antiplasmodial activity. 
 
*Corresponding author: Dr. Upma Bagai, Associate Professor, Department of Zoology, Panjab University, 
Chandigarh, India. E. mail: bagaiupma@gmail.com 
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WHY DO WE HAVE A LOT OF ANTIPLASMODIAL SUBSTANCES BUT ONLY A FEW ANTIMALARIAL 
DRUGS? 
F. Echeverri 1, Y.Upegui 2, S.M. Robledo 2 
1 Instituto de Química, Facultad de Ciencias Exactas y Naturales 
2 PECET, Instituto de Investigaciones Médicas, Facultad de Medicina, 
Universidad de Antioquia, Calle 67 No. 53–108 , Medellín 050010, Colombia 
feche@une.net.co 
 
The search of new antimalarial substances is an urgent public health necessity, since more than of half 
world people is under treat. In the other hands, in the last 50 years only a few new drugs have been 
launched in the pharmaceutical market against malaria.  
 
Traditional medicine is an excellent tool to found new molecules and to develop more and best drugs. 
However, this search and develop of natural molecules is neither easy nor cheap process, due to a number 
of factors including the follows:  
 
1. A great diversity in the bioassays and their reproducibility (protozoal stage, dose, evaluation of the 
antiplasmodial activity etc.)  
2. The use of different Plasmodium strains, some of them drug-susceptible  
3. High cytotoxicity or dose applied  
4. The lack of pure compounds instead of crude extracts  
5. The absence of in vivo assays or animal model disease  
6. In the case of animal model malaria the therapeutic scheme  
7. Non-availability of raw material to provide enough active molecules for clinical testing.  
 
Besides, there is so much confusion since molecules assayed in vitro have been more frequently reported in 
scientific journals as antimalarial.  
 
In this work these issues are discussed and a selection of the more promissory compounds from literature 
is presented, like a source of old molecules to be analyzed again in animal malarial model disease. 
 
EVALUATION OF A NOVEL MICROCIP TYPE REAL-TIME POLYMERASE CHAIN REACTION SYSTEM FOR 
MALARIA 
Mun Sub Byoun, Mi-Ae Jang, Chae Seung Lim, Sung Woo Kim 
Department of Laboratory Medicine, Korea University College of Medicine, Seoul, Korea 
 
Corresponding author: Chae Seung Lim, MD, PhD 
Department of Laboratory Medicine, Korea University Medical School, Korea University Guro Hospital, 
Guro 2 Dong, GuroGu, Seoul 152-703, Republic of Korea. 
Telephone: +82-2-2626-3245 
Fax: +82-2-2626-1465 
E-mail address: malarim@korea.ac.kr 
 
Background: Malaria is worldwide health concern and remains to be one of the most difficult infectious 
diseases to control. Early diagnosis and treatment are essential for reducing its morbidity and mortality. 
Therefore, rapid and accurate diagnosis of malaria is required. We evaluated a novel ultrafast microchip-
type real-time PCR, NBS LabChip shortened the PCR time (27 min for 45 cycles) (NanoBioSys, Seoul, 
Republic of Korea) for the identification of malaria from clinical isolates.  
 
Methods: Blood samples collected from 307 malaria suspected cases were examined by microscopy, real-
time PCR with the NBS LabChip (NBS LabChip G2-3), and a conventional tube-type real-time PCR system. 
The diagnostic accuracy of the NBS LabChip system and the agreement between the two assays were 
evaluated. 
 
Results: Among the 307 malaria suspected cases, 151 patients were confirmed to have P.vivax by 
microscopy. The NBS LabChip detected P. vivax in 150 of 156 microscopically positive samples (96.1%; 
95% confidence internal (CI), 91.4-98.4%), whereas conventional real-time PCR detected P. vivax in 151 of 
156 samples (96.8%; 95% CI, 92.3-98.8%). There were no significant differences in the sensitivity and 
specificity between the NBS LabChip and a conventional tube-type real-time PCR system (p>0.05), 
although the NBS LabChip shortened the PCR time (27 min for 45 cycles). 
 
Conclusions: The NBS LabChip G2-3 system is an ultrafast, sensitive, specific   diagnostic tool for malaria 
and can be used as a confirmatory test. 
 
TRES CANTOS ANTIMALARIAL SET-CONFIRMATION OF THE TRANSMISSION BLOCKING POTENTIAL 
OF SELECTED HITS IN THE STANDARD MEMBRANE FEEDING ASSAY (SMFA) 
S.Lozano, C.Gonzalez, J. Rodrigues, M. Almela and E.Herreros(*) 
Sonia.a.lozano@gsk.com  
(*)esperanza.a.herreros@gsk.com  
 
Discovery of transmission blocking drugs is essential for efforts to eradicate malaria. Such anti-malarial 
molecules target the mature sexual gametocyte stages of the Plasmodium parasite in the human host 
interfering with transmission to the mosquito vector and limiting the spread of the disease. The Standard 
Membrane Feeding assay is the current gold standard to determine transmission blocking (TrB) potential 
of anti-malarial compounds. Drug-treated mature gametocytes are fed via membrane to mosquitoes and 
the final assay read-out is measured by counting the mosquito midgut oocyst numbers. With the goal of 
obtaining molecules with TrB capacity, the Tres Cantos Antimalarial Set (TCAMS) with approximately 
13,533 molecules (1) was screened against stage V gametocytes using an In-vitro HTS ATP assay which 
measures ATP intracellular levels as a surrogate of gametocyte viability (2). 56 hits with activity in asexual 
and sexual stages showing a high degree of chemical novelty were selected and further six molecules 
displaying a wide range of gametocytocidal activity and representing great structural diversity within the 
drug-like space were selected for evaluation of transmission blocking potential in the SMFA (3). A complete 
block in P. falciparum transmission as measured by oocyst intensity and prevalence in Anopheles stephensi 
mosquitoes was observed with all six selected molecules. The study therefore reinforces the value of the 
SMFA as a gold standard for identifying hits with gametocytocidal activity and importantly provides new 
starting points for malaria drug discovery.   
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Symbiotc Control of Malaria Vectors 
Associate Professor Guido Favia, School of Biosciences & Veterinary Medicine, University of Camerino, 
Camerino, Italy 
Bacterial symbiosis is prevalent in insects that are efficient disease vectors, and numerous studies have 
targeted the basic mechanisms of the host–symbiont relationships to develop ways to control vector borne 
diseases. ‘Symbiotic control’ is a multifaceted approach that uses symbionts to control insect pests or 
reduce vector competence. Three such approaches currently at the cutting edge are: the disruption of 
microbial symbionts required by insect pests; the manipulation of symbionts to express anti-pathogen 
molecules within the host; and the introduction of endogenous microbes affecting life-span and vector 
capacity of the new hosts. Implication in malaria control will be discussed. 
 
Syatematic Sampling Approach Reveals Fewer Falsified First Line Antimalarials than Previously 
Reported 
Dr Harparkash Kaur, LSHTM, London, United Kingdom 
Malaria is curable provided patients have timely access to efficacious drugs, namely artemisinin based 
combination therapies (ACTs), recommended as first line treatment by the World Health Organisation. 
However, reports indicate that up to 35% of 2,296 antimalarial drugs from 21 malaria endemic countries 
were of poor quality. 
To investigate this we purchased (using three sampling approaches) and tested over 10,000 ACTs from 6 
countries. Our reassuring findings exposed only 1% fakes in 2 countries.  
Data presented will illustrate that a representative sampling approach is essential to accurately quantify 
the ineffective drugs which jeopardise treatment of a life threatening disease. 
 
Plasmodium infection of Anopheles species from the Amazon: Development of experimental 
models of neglected vectors when compared to other malaria vectors 
Dr. Paulo F. P. Pimenta, Centro de Pesquisas René Rachou Fundação Oswaldo Cruz – Brazil 
In the Americas, areas with a high risk of malaria transmission are mainly located in the Amazon Forest, 
which extends across nine countries. The establishment of experi¬mental mosquito infections with 
Plasmodium parasites can provide interesting models for studying malaria in the Amazonian scenario is 
important. The knowledge of susceptibility of Amazon anopheline populations to Plasmodium infections is 
necessary to better understand their vector capacity. In this presentation, we present data and  review the 
literature on malaria transmission from the perspective of its Amazon vectors.   
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TREATMENT OF ARTEMISININ RESISTANT MALARIA CASES WITH NOVEL FORMULATION OF 
TRADITIONAL MEDICINE IN INDIA 
Prakash U. Tahiliani 
Prime Ever Ayurvedic Research Laboratories (PEARL), Navsari, Gujarat, 396445, India. 
putahiliani@gmail.com  
 
Development of resistance by malaria parasite against anti-malarial drugs has been a big challenge in the 
treatment of malaria. In the present study, one drug prepared by me, here termed as ‘Novel Formulation of 
Traditional Medicine (NFTM)’ has been tried in 60 cases of malaria, most of them resistant to Artemisinins  
 
& ACTs, during the period of April 2009 to June 2013. All patients were given 3 days’ indoor treatment with 
NFTM. Pulse rate & Temperature was monitored 6 hourly and Blood smear examined for malaria parasite 
at 12 hours, 24 hours, 30 hours, Day-5, Day-30 & Day-60. Fever Clearance Time (FCT) observed was 30 to 
48 hours along with normalization of pulse rate. Parasite Clearance Time (PCT) was 12 to 30 hours. Fever 
clearance & Parasite clearance was observed in 98% cases of P. falciparum & 94% cases of P. vivax.  
It was observed with NFTM drug trial that (1) Need of symptomatic medication was much lesser as 
compared to that with other anti-malarials, (2) Blood count was regained, (3) Appetite returned to normal 
early, (4) Convalescence period was significantly shorter, (5) Long term recurrence was seen in 9% cases. 
(6) There was no intolerance to the drug and no adverse effect.  
It is recommended to further investigate the potentiality of this drug for the treatment of malaria. 
 
 
 
A NEW APPROACH TO MALARIA DIAGNOSIS USING INFRARED SPECTROSCOPY 
Bayden R. Wood1, Phil Heraud1, David Perez-Guita1, Aazam Khoshmanesh1, Patcharee Jearanaikoon2, 
Matthew W. A. Dixon3, Leann Tilley3 and Don McNaughton1 
1. Centre for Biospectroscopy, School of Chemistry, Monash University, 3800, Victoria, Australia 
2. Department of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon 
Kaen 40002, Thailand 
3. Department of Biochemistry and Molecular Biology and Bio21 Molecular, Science and Biotechnology 
Institute, The University of Melbourne, Melbourne, Victoria 3010 Australia 
 
Malaria is one of the most deadly diseases resulting in over 600,000 fatalities per annum.(1) Accurate and 
early diagnosis followed by the immediate treatment of the infection is essential in reducing mortality(2). 
New technologies to diagnose malaria must be cost effective and have high sensitivity to enable the 
detection of premature parasitic forms in peripheral blood. During the course of its life the malaria parasite 
transgresses through several developmental stages including a sexual and an asexual reproductive 
pathway. The detection of the rings and gametocytes at low parasitemia in peripheral blood is critical for 
early diagnosis and treatment. Here we show that Attenuated Total Reflection-Fourier Transform Infrared 
(ATR-FTIR) spectroscopy in combination with a partial least squares regression modeling has the required 
sensitivity and ease of sample preparation to become a laboratory standard for malaria detection and most 
importantly quantification.  The absolute quantification limit was found to be 0.001% (50 parasites/uL of 
blood) for cultured ring stage and gametocyte parasites in a suspension of normal erythrocytes. The 
absolute detection limit was found to be 0.00001% for laboratory cultured parasites.(3) The method is 
simple, quick and only requires the whole blood to be spun down and the plasma and white cells removed. 
The red blood cells are then fixed in methanol and a 5 μL aliquot of packed cells is placed on the diamond 
window of the ATR-FTIR spectrometer, rapidly dried and a spectrum recorded in approximately 20 
seconds. 
 
In December 2014 we commenced a pilot trial in North East Thailand investigating the potential of the 
technology to diagnose malaria in a field/clinical setting. Samples were collected from two independent 
clinics and analysed with two independent ATR-FTIR spectrometers. The results were combined and a 
Partial Least Squares Discriminant Analysis (PLS-DA) model developed and tested on a totally independent 
test set. Although the sample number was small 28 negatives and 30 positives (including patients infected 
with P. falciparum, P. vivax and a mixture of both) the replicate number was high as three aliquots for each 
sample were analysed. The percentage of correctly diagnosed spectra based on comparison with antibody 
capture rapid diagnostic test (RDT) was 97 %. The high sensitivity, low cost, ease of use, portability and 
robustness of the ATR-FTIR technique could see it become a standard diagnostic tool in both the clinic and 
remote field locations. 
 
1 C. J. L. Murray, L. C. Rosenfeld, S. S. Lim, K. G. Andrews, K. J. Foreman, D. Haring, N. Fullman, M. Naghavi, 
R. Lozano, A. D. Lopez, Global malaria mortality between 1980 and 2010: a systematic analysis. The 
Lancet 379, 413-431 (2011). 
2 K. Chotivanich, K. Silamut, N. P. J. Day, Laboratory diagnosis of malaria infection-A short review of 
methods. New Zealand Journal of Medical Laboratory Science 61, 4 (2007). 
3 Khoshmanesh, M. W. Dixon, S. Kenny, L. Tilley, D. McNaughton, B. R. Wood, Detection and 
Quantification of Early-Stage Malaria Parasites in Laboratory Infected Erythrocytes by Attenuated 
Total Reflectance Infrared Spectroscopy and Multivariate Analysis. Analytical chemistry 86, 4379-4386 
(2014). 
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DETECTION OF PLASMODIUM SPP. IN BLOOD SAMPLES FROM ANGOLA 
MA Santana-Morales1-4, AR Aragao1, P Freitas1, Quispe MA2, G Bonnet1, P Berzosa3-4, B Valladares1-4, E 
Martinez-Carretero1-4 
1 University Institute of Tropical Diseases and Public Health of the Canary Islands University of La Laguna, 
Tenerife-Spain. 
2 University San Antonio Abad, Cuzco-Peru. 
3 National Centre of Tropical Medicine, Institute of Health Carlos III, Madrid-Spain. 
4 The Spanish Tropical Diseases Research Network (RICET in Spanish), Madrid-Spain. msanmor@ull.edu.es 
 
According to the Angolan National Malaria Control Programme, malaria remains a major problem in 
Angola. The entire population is at risk of infection, and according to Ministry of Health estimates, 
Plasmodium falciparum accounts for 92% of infections, followed by P. vivax in about 7% of cases (COSEP 
2011). Other study showed that the majority of cases of malaria are caused by P. falciparum (87%); P. 
vivax, P. ovale, and P. malariae represented 7%, 3%, and 3% of cases, respectively (PMI 2014). This 
situation could be changing and the infection caused by species of Plasmodium different to P. falciparum 
can be gaining higher presence in some parts of Africa. 
 
The aim of this study was to investigate the presence of Plasmodium in two Angola region (Luanda y 
Caxito) and determine the proportion of the different species detected. 
 
This study was conducted in Luanda and Caxito during April-June in 2009. A sample of 434 outpatients 
(age range, 5 to 70 years) was randomly selected from health facility posts. One capillary blood specimen is 
taken from each patient on filter paper (Whatman C 3MM) for molecular assay. Blood samples were 
assayed by SnM-PCR, according to the protocol of Rubio et al. 1999, for detection of Plasmodium species.  
 
The presence of infection in Luanda was 5,5% of the total samples, where the three species of Plasmodium 
(P. falciparum, P. vivax and P. ovale) were identified. P. falciparum showed the highest infection rate with 
54.5% of the positives samples. In the case of the other species, the infection rate was 36.4% of P. vivax and 
9.1% of P. ovale.  
 
In Caxito, 18% of the samples were positives for Plasmodium. In this area, the three species of Plasmodium 
(P. falciparum, P. vivax and P. ovale) were identified and mix infection too. The infection rate in the 
different species was 45.2% of P. falciparum, 38.1% of P. vivax, 12% of P. ovale and 4.7% of mix infection 
(P.f.-P.v.). 
 
In this study, Plasmodium frequency in Caxito was three times higher than in Luanda. In both regions, the 
three Plasmodium species (P. falciparum, P. vivax and P. ovale) were detected in the study population.  
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